| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/19/2007 | EP1834963A1 Di-polymer protein conjugates and processes for their preparation |
| 09/19/2007 | EP1834962A1 PEGylated mtutated Clostridium botulinum toxin |
| 09/19/2007 | EP1834652A1 Dialysis preparation |
| 09/19/2007 | EP1834650A1 Cancer vaccine preparation |
| 09/19/2007 | EP1834646A1 Ultrasonic cancer therapy accelerator and cytotoxic agent |
| 09/19/2007 | EP1834634A2 Pharmaceutical multiple-unit composition |
| 09/19/2007 | EP1833904A1 Water-dispersible xanthan gum containing composition |
| 09/19/2007 | EP1833882A1 Hyaluronic acid linked with a polymer of an alpha hydroxy acid |
| 09/19/2007 | EP1833879A1 Poly(ester amide) block copolymers |
| 09/19/2007 | EP1833855A2 Method for controlling the dimensions and the morphology of nanostructural polymeric materials, materials thereby obtained and uses thereof |
| 09/19/2007 | EP1833469A2 Pharmaceutical composition of acid labile substances |
| 09/19/2007 | EP1833468A1 Tablet formulation for sustained drug-release |
| 09/19/2007 | EP1833462A2 Pharmaceutical manufacturing process for heat sterilised glucocorticoid suspensions |
| 09/19/2007 | EP1768491A4 Methods and compositions for controlling parasitic infections of animals |
| 09/19/2007 | EP1732524A4 Methods and compositions for treatment of ion imbalances |
| 09/19/2007 | EP1656113B1 Method for the production of effervescent granules in a vacuum |
| 09/19/2007 | EP1511517B1 Formulation for parenteral administration of sodium channel blockers |
| 09/19/2007 | EP1418946B1 Bioactive surface modifiers for polymers and articles made therefrom |
| 09/19/2007 | EP1408911B1 Sustained-release therapeutic bioadhesive systems |
| 09/19/2007 | EP1333819B1 Inhalative solution formulation containing a tiotropium salt |
| 09/19/2007 | EP1192134B1 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol |
| 09/19/2007 | CN200948290Y Moxibustion patch |
| 09/19/2007 | CN101039965A 唾液酸衍生物 Sialic acid derivatives |
| 09/19/2007 | CN101039702A Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| 09/19/2007 | CN101039701A Prodrugs and codrusgs containing bio-cleavable disulfide linkers |
| 09/19/2007 | CN101039700A Vaccine conjugate including a human chorionic gonadotropin beta subunit antigen linked to an anti-mannose receptor (mr) antibody |
| 09/19/2007 | CN101039699A Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 09/19/2007 | CN101039698A Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation |
| 09/19/2007 | CN101039695A Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes |
| 09/19/2007 | CN101039682A Sulfoalkyl ether-alkyl ether cyclodextrin derivatives |
| 09/19/2007 | CN101039660A Stable pegylated interferon formulation |
| 09/19/2007 | CN101039657A Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose |
| 09/19/2007 | CN101039656A Enteric nutritional supplement |
| 09/19/2007 | CN101037494A Microgel with nanometer grade sensitivity of temperature and PH value and preparation method thereof |
| 09/19/2007 | CN101037471A Half electric charge matching nonapeptide and application thereof |
| 09/19/2007 | CN101036788A Pulullan polysaccharide carrier material having the function of targeting therapy of cancer and the preparation method |
| 09/19/2007 | CN101036785A Chitosan nanoparticles oral preparations of hepatitis vaccine |
| 09/19/2007 | CN101036770A External emplastrum for treating deficiency-cold for children |
| 09/19/2007 | CN101036719A Sirup agent for curing cough for children and the preparing method |
| 09/19/2007 | CN101036695A Oil-in-water type nanometer emulsion elecampane oil and litsea citrata oil and the method for preparing the same |
| 09/19/2007 | CN101036694A External emplastrum for curing child demonstration and the method for preparing the same |
| 09/19/2007 | CN101036668A Grain agent including polyethylene glycol 4000 |
| 09/19/2007 | CN101036663A Medicinal composition containing hydroxypropyl Zhigan and its preparing process |
| 09/19/2007 | CN101036657A Stable cefoperazone medicine prparation |
| 09/19/2007 | CN101036656A Stable cefoperazone tazobactam medicine compound preparation |
| 09/19/2007 | CN101036654A Stable cefoperazone sulbactam medicine compound preparation |
| 09/19/2007 | CN101036648A Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 09/19/2007 | CN101036644A Pharmaceutical composition containing arctigenin and preparation method |
| 09/19/2007 | CN101036643A Pharmaceutical composition containing arctigenin and preparation method |
| 09/19/2007 | CN101036642A Ginkgolide B nanometric liposomes medicine and the preparing method thereof |
| 09/19/2007 | CN101036635A Compound diisopropylamine dichloroacetate sodium chloride injecta |
| 09/19/2007 | CN101036633A Enteric coated omeprazole pellets capsule and the preparing method thereof |
| 09/19/2007 | CN101036632A Sustained release preparation of cinmetacin |
| 09/19/2007 | CN100338086C Immunostimulatory nucleic acid molecules |
| 09/19/2007 | CN100337712C Method of reducing impurity content in aqueous salt solution |
| 09/19/2007 | CN100337689C Polyalkylene glycol acid additives |
| 09/19/2007 | CN100337688C Biological compactable medicine carrier and its preparing method |
| 09/19/2007 | CN100337687C Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 09/19/2007 | CN100337641C Antipyrotic and method of manufacturing the same |
| 09/19/2007 | CN100337630C Palatable oral suspension and method |
| 09/19/2007 | CN100337620C Water-soluble composition containing coenzyme q10 |
| 09/19/2007 | CN100337614C Medicinal aerosol formulation |
| 09/19/2007 | CN100337613C Effervescence particles and preparing method thereof |
| 09/19/2007 | CN100337549C Prebiotic and probiotic compositions and method for use in gut-based therapies |
| 09/19/2007 | CN100337545C Liquid formulations for dernal application in treatment of parasitic insects in animals |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271252 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 09/18/2007 | US7271145 Artificial blood; mixture of surface treated hemoglobin in aqueous diluent |
| 09/18/2007 | US7270834 For use in the treatment of several diseases such as diseases of the feet in animals, such as the hooves in horses, arthritis, muscular affections, etc. in human beings |
| 09/18/2007 | US7270832 Carriers for administration of active principles such as drugs or nutriments, cosmetic products or plant health products such as herbicides, pesticides, insecticides, fungicides, etc. |
| 09/18/2007 | US7270829 Industrial production of meat using cell culture methods |
| 09/18/2007 | US7270808 Having covalently coupled bioactive agent and targeting ligand; controlled release; stability, solubility; reduced toxicity |
| 09/18/2007 | CA2414680C Methods for treating inflammation-mediated conditions of the eye |
| 09/18/2007 | CA2413624C Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode |
| 09/18/2007 | CA2392473C Bioadhesive drug delivery system |
| 09/18/2007 | CA2388325C Ciclesonide-containing aqueous pharmaceutical composition |
| 09/18/2007 | CA2388322C Ciclesonide contained pharmaceutical composition for application to mucosa |
| 09/18/2007 | CA2319609C Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
| 09/18/2007 | CA2304662C Methods for fabricating polymer-based controlled release preparations |
| 09/18/2007 | CA2297832C Pellet-type formulation intended for treating the intestinal tract |
| 09/18/2007 | CA2282513C Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 09/18/2007 | CA2248179C .beta.-lactam antibiotic-containing tablet and production thereof |
| 09/18/2007 | CA2216919C Nanospheres comprising a biocompatible polysaccharide |
| 09/18/2007 | CA2176719C Fatty acid delivery system |
| 09/18/2007 | CA2164193C Intravaginal preparation containing physiologically active peptide |
| 09/13/2007 | WO2007103348A2 Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| 09/13/2007 | WO2007103132A2 Method and apparatus for acne treatment using low intensity light therapy |
| 09/13/2007 | WO2007102608A1 Stabilizer for hydrophobic compounds |
| 09/13/2007 | WO2007102594A1 Polymer complex |
| 09/13/2007 | WO2007102481A1 Vector for nuclear transport of substance |
| 09/13/2007 | WO2007102447A1 Adhesive microcapsule |
| 09/13/2007 | WO2007102243A1 External pharmaceutical composition |
| 09/13/2007 | WO2007102242A1 External pharmaceutical composition |
| 09/13/2007 | WO2007102241A1 External pharmaceutical composition |
| 09/13/2007 | WO2007101915A1 Method for enhancing cyclodextrin complexation |
| 09/13/2007 | WO2007101560A1 Medicament formulations comprising fluoroquinolones |
| 09/13/2007 | WO2007101400A1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
| 09/13/2007 | WO2007101332A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | WO2007101331A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/13/2007 | WO2007071915A3 Pharmaceutical product comprising porous silicon |